Composite Government Tracker Insider Trading Hedge Funds Red Flags Financials

Financials

HUMA

Humacyte, Inc. · Biological Products, (No Diagnostic Substances)

Financials Score

★★★★★

Metrics Available9 / 10

You vs. Peer Average

Gross Margin

HUMA

-376.1%

Peers

67.2%

Operating Margin

HUMA

-5306.0%

Peers

26.7%

Net Margin

HUMA

-2003.6%

Peers

18.9%

Earnings Growth (YoY)

HUMA

72.5%

Peers

20.8%

Return on Equity

HUMA

-1313.4%

Peers

3.5%

Return on Assets

HUMA

-35.1%

Peers

4.4%

Debt / Equity

HUMA

11.40x

Peers

0.30x

Current Ratio

HUMA

3.69x

Peers

3.39x

FCF Margin

HUMA

-5197.5%

Peers

24.1%